Ren-Wang Peng - Search Results

Year	Number of Results
2005	1
2007	1
2009	2
2010	3
2011	2
2016	2
2017	1
2018	3
2019	8
2020	12
2021	10
2022	10
2023	3
2024	1

1

Multi-scale integrative analyses identify THBS2⁺ cancer-associated fibroblasts as a key orchestrator promoting aggressiveness in early-stage lung adenocarcinoma.

Yang H, Sun B, Fan L, Ma W, Xu K, Hall SRR, Wang Z, Schmid RA, Peng RW, Marti TM, Gao W, Xu J, Yang W, Yao F. Yang H, et al. Among authors: peng rw. Theranostics. 2022 Mar 28;12(7):3104-3130. doi: 10.7150/thno.69590. eCollection 2022. Theranostics. 2022. PMID: 35547750 Free PMC article.

2

Battles against aberrant KEAP1-NRF2 signaling in lung cancer: intertwined metabolic and immune networks.

Xu K, Ma J, Hall SRR, Peng RW, Yang H, Yao F. Xu K, et al. Among authors: peng rw. Theranostics. 2023 Jan 1;13(2):704-723. doi: 10.7150/thno.80184. eCollection 2023. Theranostics. 2023. PMID: 36632216 Free PMC article. Review.

3

Revisiting "BAP1ness" in Malignant Pleural Mesothelioma.

Yang H, Yao F, Peng RW. Yang H, et al. Among authors: peng rw. J Thorac Oncol. 2022 Aug;17(8):e67-e69. doi: 10.1016/j.jtho.2022.04.014. J Thorac Oncol. 2022. PMID: 35931424 Free article. No abstract available.

4

Biomarker-guided targeted and immunotherapies in malignant pleural mesothelioma.

Yang H, Xu D, Schmid RA, Peng RW. Yang H, et al. Among authors: peng rw. Ther Adv Med Oncol. 2020 Nov 12;12:1758835920971421. doi: 10.1177/1758835920971421. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 33240401 Free PMC article. Review.

5

New Horizons in KRAS-Mutant Lung Cancer: Dawn After Darkness.

Yang H, Liang SQ, Schmid RA, Peng RW. Yang H, et al. Among authors: peng rw. Front Oncol. 2019 Sep 25;9:953. doi: 10.3389/fonc.2019.00953. eCollection 2019. Front Oncol. 2019. PMID: 31612108 Free PMC article. Review.

6

A Breakthrough Brought about by Targeting KRAS^G12C: Nonconformity Is Punished.

Ning W, Yang Z, Kocher GJ, Dorn P, Peng RW. Ning W, et al. Among authors: peng rw. Cancers (Basel). 2022 Jan 13;14(2):390. doi: 10.3390/cancers14020390. Cancers (Basel). 2022. PMID: 35053550 Free PMC article. Review.

7

Non-genetic adaptive resistance to KRAS^G12C inhibition: EMT is not the only culprit.

Ning W, Marti TM, Dorn P, Peng RW. Ning W, et al. Among authors: peng rw. Front Oncol. 2022 Nov 22;12:1004669. doi: 10.3389/fonc.2022.1004669. eCollection 2022. Front Oncol. 2022. PMID: 36483040 Free PMC article. Review.

8

Beyond DNA Repair: DNA-PKcs in Tumor Metastasis, Metabolism and Immunity.

Yang H, Yao F, Marti TM, Schmid RA, Peng RW. Yang H, et al. Among authors: peng rw. Cancers (Basel). 2020 Nov 16;12(11):3389. doi: 10.3390/cancers12113389. Cancers (Basel). 2020. PMID: 33207636 Free PMC article. Review.

9

Organoids as a Model for Precision Medicine in Malignant Pleural Mesothelioma: Where Are We Today?

Gao Y, Kruithof-de Julio M, Peng RW, Dorn P. Gao Y, et al. Among authors: peng rw. Cancers (Basel). 2022 Aug 2;14(15):3758. doi: 10.3390/cancers14153758. Cancers (Basel). 2022. PMID: 35954422 Free PMC article. Review.

10

Dendritic cell/cytokine-induced killer cell-based immunotherapy in lung cancer: What we know and future landscape.

Mohsenzadegan M, Peng RW, Roudi R. Mohsenzadegan M, et al. Among authors: peng rw. J Cell Physiol. 2020 Jan;235(1):74-86. doi: 10.1002/jcp.28977. Epub 2019 Jun 21. J Cell Physiol. 2020. PMID: 31222740 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

53 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year